Anonymous
Guest
Anonymous
Guest
MiMedx: Not What The Doctor Ordered
Mar. 21, 2014 11:30 AM ET | About: MiMedx Group Inc. (MDXG)
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary
Company hands out over 1 million shares of stock and options worth over $7 million to doctor consultants and medical advisory board members.
Practices raise ethical questions, risk of federal violations that have damaged other companies.
Company market cap of about $740 million greatly exceeds estimated $500 million “skin substitution” market.
Doctors, insiders, employees hold options/warrants on over 16 million shares of stock at 90 cents to $2.46.
Analyst slaps MiMedx with lack-luster “market perform” and notes looming uncertainties, issues.
Human placenta products peddler MiMedx (MDXG) is handing out company stock like candy to doctors who "evaluate technologies" or act as consultants, TheStreetSweeper has learned.
One doctor got tens of thousands of shares of common stock without paying one single dime. Another prominent doctor on the company's medical advisory board received options on 200,000 shares.
The company has doled out roughly 1.2 million shares of stock and options to its influential doctor friends - shares now worth more than $7 million - as its chief executive, Parker Petit, prepares to go on trial perhaps as early as next month for an alleged insider trading scheme.
Despite that, the company's stock price is screaming, shoving the market cap into the stratosphere. The company is now valued at about $740 million, much higher than the entire "skin substitution" market estimated at $500 million.
Paid to do what?
MiMedx uses doctors in speaking bureaus, consulting and research. But filings also say doctors educate others about "the efficacy and uses of our products." MiMedx's business turns mothers' placental membranes into "EpiFix" material used to cover injuries such as burns and diabetic foot sores, as well as "AmnioFix" for internal coverage uses such as spinal surgery and tennis elbow.
Mar. 21, 2014 11:30 AM ET | About: MiMedx Group Inc. (MDXG)
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary
Company hands out over 1 million shares of stock and options worth over $7 million to doctor consultants and medical advisory board members.
Practices raise ethical questions, risk of federal violations that have damaged other companies.
Company market cap of about $740 million greatly exceeds estimated $500 million “skin substitution” market.
Doctors, insiders, employees hold options/warrants on over 16 million shares of stock at 90 cents to $2.46.
Analyst slaps MiMedx with lack-luster “market perform” and notes looming uncertainties, issues.
Human placenta products peddler MiMedx (MDXG) is handing out company stock like candy to doctors who "evaluate technologies" or act as consultants, TheStreetSweeper has learned.
One doctor got tens of thousands of shares of common stock without paying one single dime. Another prominent doctor on the company's medical advisory board received options on 200,000 shares.
The company has doled out roughly 1.2 million shares of stock and options to its influential doctor friends - shares now worth more than $7 million - as its chief executive, Parker Petit, prepares to go on trial perhaps as early as next month for an alleged insider trading scheme.
Despite that, the company's stock price is screaming, shoving the market cap into the stratosphere. The company is now valued at about $740 million, much higher than the entire "skin substitution" market estimated at $500 million.
Paid to do what?
MiMedx uses doctors in speaking bureaus, consulting and research. But filings also say doctors educate others about "the efficacy and uses of our products." MiMedx's business turns mothers' placental membranes into "EpiFix" material used to cover injuries such as burns and diabetic foot sores, as well as "AmnioFix" for internal coverage uses such as spinal surgery and tennis elbow.